The Technical Analyst
Select Language :
Proteonomix, Inc. [PROT]

Exchange: OTC Sector: Healthcare Industry: Biotechnology

Proteonomix, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Proteonomix, Inc. is listed at the  Exchange

0.00% $0.0000

America/New_York / 21 des 2023 @ 11:01


Proteonomix, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 0.0160 mill
EPS: 0
P/E: 0
Earnings Date: N/A
SharesOutstanding: 15 979 mill
Avg Daily Volume: 0 mill
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0 | sector: PE 29.05
PE RATIO: COMPANY / INDUSTRY
N/A
Company: PE 0 | industry: PE 136.10
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.0000 - 0.0000

( +/- 0.00%)
ATR Model: 14 days

Forecast: 01:40 - $0

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.0000 (0.00% )
Volume 0.0000 mill
Avg. Vol. 0 mill
% of Avg. Vol 0 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Proteonomix, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Proteonomix, Inc.

RSI

Intraday RSI14 chart for Proteonomix, Inc.

Last 10 Buy & Sell Signals For PROT

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Proteonomix, Inc.

PROT

Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.

Last 10 Buy Signals

Date Signal @
RNDRUSDMay 6 - 04:469.90
SCANA.OLMay 6 - 04:31NOK2.24
DNO.OLMay 6 - 04:28NOK10.38
AKH.OLMay 6 - 04:29NOK3.34
DESOUSDMay 6 - 04:4121.77
YFIUSDMay 6 - 04:41$7 099.25
USDTUSDMay 6 - 04:35$1.000
BEWI.OLMay 6 - 04:19NOK29.45
YAR.OLMay 6 - 04:18NOK316.70
BORR.OLMay 6 - 04:17NOK59.55

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.